Company profile
CanimGuide Therapeutics company profile
CanImGuide is developing a therapeutic platform based around an extraordinary biologic concept and an entirely new mechanism of action for immunomodulation. They have discovered and thoroughly demonstrated, that a previously unknown immunosuppressive peptide named P3028 is formed in malignant tumors through the breakdown of albumin. This intra-tumoral albumin peptide binds to the fundamental receptor.
Business identity
- Website
- https://canimguide.com/
- Contact email
- [email protected]
- Phone number
- +46 730 870 660
- Operating status
- Active
- Founded
- 2006-01-01
Headquarters
- Headquarters
- Lund, Skane Lan, Sweden
- Postal code
- 223 81
- Country code
- SE
- Continent
- Europe